1. Introduction {#sec1-molecules-21-01175}
===============

The plant *Aconitum szechenyianum* Gay., a species in the *Aconitum* genus of Ranunculaceae, is widely distributed in the west of China and used as a folk medicine in Shaanxi province, known as "Tie-Bang-Chui" \[[@B1-molecules-21-01175]\]. Phytochemical studies revealed that *A. szechenyianum* contained mainly C~19~ and C~20~ diterpenoid alkaloids \[[@B2-molecules-21-01175],[@B3-molecules-21-01175],[@B4-molecules-21-01175],[@B5-molecules-21-01175]\], possessing aconitine-type, 7,17-secoaconitine-type, and napeline-type skeletons. Aconitine-type have no oxygen-containing functionality at C-7, and secoaconitine-type skeleton contains N, C-17, and C-7, C-8 double bonds. Pharmacological studies revealed that these C~19~ and C~20~ diterpenoid alkaloids had demonstrated various activities as anti-inflammatory, analgesic, anticancer, anti-epileptiform, antiparasite, and cardiovascular action \[[@B6-molecules-21-01175],[@B7-molecules-21-01175]\]. As part of our research project to explore more bioactive lead compounds from the medicinal herbs in the Qinba mountains of China \[[@B8-molecules-21-01175],[@B9-molecules-21-01175],[@B10-molecules-21-01175],[@B11-molecules-21-01175],[@B12-molecules-21-01175],[@B13-molecules-21-01175],[@B14-molecules-21-01175],[@B15-molecules-21-01175],[@B16-molecules-21-01175]\], the chemical constituents and pharmacological studies of *A. szechenyianum* were studied, and three new C~19~-norditerpenoid alkaloids, *szechenyianine* A (**1**), *szechenyianine* B (**2**), and *szechenyianine* C (**3**), along with two known ones, *N*-deethyl-3-acetylaconitine (**4**) and *N*-deethyldeoxyaconitine (**5**) were isolated ([Figure 1](#molecules-21-01175-f001){ref-type="fig"}). Since the roots of *A. szechenyianum* were commonly used to treat rheumatism and fracture \[[@B17-molecules-21-01175]\], the isolated compounds were evaluated for their effects on the inhibition of NO production on LPS-activated RAW264.7 cells ([Table 2](#molecules-21-01175-t002){ref-type="table"} and [Figure 5](#molecules-21-01175-f005){ref-type="fig"}), and the structure-activity relationship of these compounds were discussed.

2. Results and Discussion {#sec2-molecules-21-01175}
=========================

*Szechenyianine* A (**1**) was isolated as a white amorphous powder and showed a positive reaction with Dragendorff′s reagent. Its molecular formula C~32~H~41~NO~10~ was derived from a protonated molecular ion peak at *m/z* 600.2842 \[M + H\]^+^ (calcd. 600.2809) of the HR-ESI-MS spectrum. Comparison of the NMR data of **1** and **5**, indicated almost similar NMR spectroscopic features, except for the number of C-4, C-17, C-19, this deduction was also confirmed by the chemical shift ([Table 1](#molecules-21-01175-t001){ref-type="table"}) of C-4 (δ~C~ 39.0), C-19 (δ~C~ 49.0), and C-17 (δ~C~ 56.7) to upfield in ^13^C-NMR spectra of **5** compared with C-4 (δ~C~ 46.8), C-19 (δ~C~ 165.9) and C-17 (δ~C~ 60.6) of **1,** we predicted the existence of *N*=CH group in compound **1**. The ^1^H-NMR spectrum ([Table 1](#molecules-21-01175-t001){ref-type="table"}) of **1** showed the presence of five aromatic proton signals due to a monosubstituted benzene at δ~H~ 8.02 (2H, d, *J* = 7.6 Hz), 7.55 (1H, t, *J* = 7.6 Hz), and 7.43 (2H, t, *J* = 7.6 Hz); a methine proton of an *N* = CH group at δ~H~ 7.31 (1H, s), four OMe protons at δ~H~ 3.75 (3H, s), 3.29 (3H, s), 3.18 (3H, s), and 3.03 (3H, s); and a strongly shielded proton of an acetoxyl group at δ~H~ 1.32 (3H, s). The ^13^C-NMR spectrum ([Table 1](#molecules-21-01175-t001){ref-type="table"}) displayed 32 carbon resonances. Among them, resonances at δ~C~ 166.2, 133.6, 130.0, 129.8 (C × 2), and 128.9 (C × 2) were attributed to a benzoyloxy group; δ~C~ 61.3, 59.3, 57.4 and 56.3 were attributed to four OMe groups, δ~C~ 172.6 and 21.5 were attributed to an acetoxyl group, and the NMR features of the remained 19 resonances were characteristic to an aconitine-type alkaloid, in which δ~C~ 165.9 was attributed to a *N*=CH group and δ~C~ 74.3 and 78.9 were attributed to two oxygenated carbons associated with hydroxyl groups. The assignments of the NMR signals associated with **1** were derived from HSQC, HMBC, and ROESY experiments. In the HMBC spectrum ([Figure 2](#molecules-21-01175-f002){ref-type="fig"}), correlations of H-5 (δ~H~ 2.23) and H-17 (δ~H~ 3.97) to C-19 (δ~C~ 165.9) suggested that C-19 was involved in the *N*=CH group; correlation of H-14 (δ~H~ 4.90) to the carbonyl carbon signal of benzoyl group (δ~C~ 166.2) suggested that the benzoyl group was located at C-14; correlation of the proton signal of the acetoxyl group (δ~H~ 1.32) to C-8 (δ~C~ 90.6) suggested the acetoxyl group was located at C-8; correlations of OCH~3~ (δ~H~ 3.18) to C-1 (δ~C~ 82.3), OCH~3~ (δ~H~ 3.03) to C-6 (δ~C~ 84.1), OCH~3~ (δ~H~ 3.75) to C-16 (δ~C~ 89.9), and OCH~3~ (δ~H~ 3.29) to C-18 (δ~C~ 78.2) suggested four methoxyl groups were linked at C-1, C-6, C-16, and C-18, respectively; correlations of H-12 (δ~H~ 2.20, 2.21), H-14 (δ~H~ 4.90), and H-16 (δ~H~ 3.42) to C-13 (δ~C~ 74.3), H-9 (δ~H~ 2.70) and H-16 (δ~H~ 3.42) to C-15 (δ~C~ 78.9), suggested two hydroxyl groups were linked at C-13 and C-15, respectively. Thus, the planar structure of **1** was deduced as 14-benzoyloxy-8-acetoxyl-13,15-dihydroxy-1,6,16,18-tetramethoxy-19-en-aconitane. Meanwhile, in the ROSEY spectrum ([Figure 2](#molecules-21-01175-f002){ref-type="fig"}) of **1**, the NOE correlations of H-1/H-10, H-10/H-14, H-14/H-9, and H-9/H-6 indicated β-orientation of H-1, H-6, H-9, H-10, and H-14, and α-axial configurations of 1-OCH~3~, 6-OCH~3~ and 14-benzoyloxy; NOE correlations of H-6/H-5 and H-5/H-18 revealed β-orientation of H-18 and 18-OCH~3~, and α-axial of H-19; NOE correlations of H-17/H-7, H-16 and 15-OH, revealed α-axial of H-16, H-17 and 15-OH, and β-orientation of 16-OCH~3~, 13-OH and 8-acetoxyl. Moreover, the NOE correlations of H-1/H-3 and H-5 while no correlation between H-2 and H-5 indicated **1** had ring A (C-1, C-2, C-3, C-4, C-5, and C-11) in the chair conformation. Thus, according to the literature \[[@B18-molecules-21-01175]\], compound **1** was assigned the name as (A-*c*)-14α-benzoyloxy-8β-acetoxyl-13β,15α-dihydroxy-1α,6α,16β,18β-tetramethoxy-19-en-aconitane.

S*zechenyianine* B (**2**) was isolated as a white amorphous powder. The NMR spectroscopic data indicated that **2** was an analogu of **1** with similar skeleton and substituent groups. However, the molecular formula of **2** was deduced as C~32~H~41~NO~11~ from the protonated molecular ion peak at *m/z* 616.2783 \[M + H\]^+^ (calcd. 616.2758), suggesting that an *N*-oxidation group was included in compound **2**. This deduction was also confirmed by the chemical shift ([Table 1](#molecules-21-01175-t001){ref-type="table"}) of C-4 (δ~C~ 42.1) and C-19 (δ~C~ 138.9) to upfield, and C-17 (δ~C~ 72.9) to downfield in ^13^C-NMR spectra of **2** compared with C-4 (δ~C~ 46.8), C-19 (δ~C~ 165.9) and C-17 (δ~C~ 60.6) of **1**. Thus, compound **2** was identified by HSQC, ^1^H-^1^H COSY, HMBC, and ROESY experiments ([Table 1](#molecules-21-01175-t001){ref-type="table"} and [Figure 3](#molecules-21-01175-f003){ref-type="fig"}) as (A-*c*)-14α-benzoyloxy-8β-acetoxyl-13β,15α-dihydroxy-1α,6α,16β,18β-tetra-methoxy-19-en-aconitane-*N*-oxide.

*Szechenyianine* C (**3**) was isolated as a white amorphous powder. Its molecular formula C~30~H~39~NO~8~ was derived from a protonated molecular ion peak at *m/z* 542.2783 \[M + H\]^+^ (calcd. 542.2754) of the HR-ESI-MS spectrum. The ^1^H-NMR spectrum ([Table 1](#molecules-21-01175-t001){ref-type="table"}) of **3** showed the presence of five aromatic protons signals due to a monosubstituted benzene at δ~H~ 8.03 (2H, d, *J* = 7.5 Hz), 7.53 (1H, t, *J* = 7.5 Hz), and 7.42 (2H, t, *J* = 7.5 Hz); two olefinic protons signals at δ~H~ 7.86 (1H, brs) due to *N*=CH and δ~H~ 5.62 (1H, d, *J* = 5.5 Hz) due to C=CH, respectively; and four OMe protons at δ~H~ 3.75 (3H, s), 3.27 (3H, s), 3.20 (3H, s) and 3.19 (3H, s). The ^13^C-NMR spectrum ([Table 1](#molecules-21-01175-t001){ref-type="table"}) displayed 30 carbon resonances. Among them, resonances at δ~C~ 166.4, 133.5, 130.0, 130.1 (C × 2) and 128.7 (C × 2) were attributed to a benzoyl group; δ~C~ 61.8, 59.1, 58.2 and 56.9 were attributed to four OMe groups; and the NMR features of the remained 19 resonances were characteristic to a 7, 17-secoaconitine alkaloid, in which δ~C~ 166.4 was attributed to a *N*=CH group, and δ~C~ 132.1 and 137.5 were attributed to an olefinic bond. In the HMBC spectrum ([Figure 4](#molecules-21-01175-f004){ref-type="fig"}), correlations of H-1 (δ~H~ 2.99), H-5 (δ~H~ 2.32), H-10 (δ~H~ 2.43), and H-19 (δ~H~ 3.53) to C-17 (δ~C~ 166.4) suggested that C-17 was involved in the *N*=CH group, and correlations of H-5 (δ~H~ 2.32), H-6 (δ~H~ 4.45) to C-7 (δ~C~ 132.1), H-6 (δ~H~ 4.45), H-14 (δ~H~ 5.08), and H-15 (δ~H~ 4.80) to C-8 (δ~C~ 137.5) suggested the olefinic bond was located at C-7 and C-8, which supported the presence of skeleton of the 7,17-secoaconitine alkaloid. Moreover, HMBC correlation of H-14 (δ~H~ 5.08) to the carbonyl carbon signal of benzoyl group (δ~C~ 166.4) suggested that the benzoyl group was located at C-14; correlations of OCH~3~ (δ~H~ 3.20) to C-1 (δ~C~ 89.6), OCH~3~ (δ~H~ 3.19) to C-6 (δ~C~ 80.1), OCH~3~ (δ~H~ 3.75) to C-16 (δ~C~ 92.2), and OCH~3~ (δ~H~ 3.27) to C-18 (δ~C~ 80.6) suggested four methoxyl groups were linked at C-1, C-6, C-16 and C-18, respectively; correlations of H-10 (δ~H~ 2.43) and H-14 (δ~H~ 5.08) to C-13 (δ~C~ 75.6), H-7 (δ~H~ 5.62) and H-16 (δ~H~ 3.30) to C-15 (δ~C~ 74.1) suggested two hydroxyl group were linked at C-13 and C-15, respectively. Thus, the planar structure of **3** was deduced as 14-benzoyloxy-13,15-dihydroxy-1,6,16,18-tetramethoxy-7(8),17-dien-7,17-secoaconitane. Meanwhile, in the ROSEY spectrum ([Figure 4](#molecules-21-01175-f004){ref-type="fig"}) of **3**, the NOE correlations of H-1/H-10, H-10/H-14 and H-14/H-9 indicated *β*-orientation of H-1, H-9, H-10 and H-14, and α-axial configurations of 1-OCH~3~ and 14-benzoyloxy; the NOE correlations of H-6/H-5 and H-5/H-18 revealed β-orientation of H-18 and 18-OCH~3~, and α-axial of 6-OCH~3~; NOE correlations of H-17/H-16 and 15-OH, H-15/16-OCH~3~ revealed α-axial of H-16 and 15-OH, and β-orientation of 16-OCH~3~ and 13-OH. Moreover, the NOE correlations of H-1/H-3 and H-5 while no correlation between H-2 and H-5 indicated **3** had ring A (C-1, C-2, C-3, C-4, C-5, and C-11) in the chair conformation. Thus, according to the literature \[[@B18-molecules-21-01175]\], compound **3** was assigned the name as (A-*c*)-14α-benzoyloxy-13β, 15α-dihydroxy-1α,6α,16β,18β-tetramethoxy-7(8),17-dien-7,17-secoaconitane.

Since the roots of *A. szechenyianum* are commonly used to treat rheumatism and fracture \[[@B17-molecules-21-01175]\], in which inflammation is involved in the pathophysiological process and inhibitors of NO release are considered as potential anti-inflammatory agents for the treatment of these diseases \[[@B18-molecules-21-01175],[@B19-molecules-21-01175],[@B20-molecules-21-01175]\], the isolated compounds from *A. szechenyianum* were evaluated using the Griess assay \[[@B21-molecules-21-01175]\] for their effects on the inhibition of NO production in LPS-activated RAW264.7 cells. Dexamethasone (DEX) was selected as a positive control. As shown in [Table 2](#molecules-21-01175-t002){ref-type="table"} and [Figure 5](#molecules-21-01175-f005){ref-type="fig"}, all compounds with aconitine or 7,17-secoaconitine skeleton exhibited anti-inflammatory activities in a dose-dependent manner. Compared the activity with the substituent groups of **1**, **2**, **4**, and **5**, the structure-activity relationship may be due to the chemical environment of *N* atom. The compound **1** could hinder the inhibition of NO production with IC~50~ value of 36.62 ± 6.86 μM. The compound **2** exhibited excellent active performance with IC~50~ value of 3.30 ± 0.11 μM, indicated that the presence of *N*→O might increase anti-inflammatory activities. Moreover, compound **4** exhibited effective inhibitory activity with IC~50~ value of 8.09 ± 1.31 μM and compound **5** showed inhibitory activity with IC~50~ value of 11.73 ± 1.94 μM. In addition, compound **3** as a 7,17-secoaconitine type alkaloid also exhibited potent inhibitory activity on NO production with IC~50~ value of 7.46 ± 0.89 μM.

3. Experimental Section {#sec3-molecules-21-01175}
=======================

3.1. General Information {#sec3dot1-molecules-21-01175}
------------------------

ESI-MS was performed on a Quattoro Premier instrument (Waters, Milford, MA, USA). The HR-ESI-MS spectra were recorded on an Agilent Technologies 6550 Q-TOF (Santa Clara, CA, USA). 1D and 2D-NMR spectra were recorded on Bruker-AVANCE 400 instrument (Bruker, Rheinstetten, Germany) with TMS as an internal standard. The analytical HPLC was performed on a Waters e2695 Separations Module coupled with a 2998 Photodiode Array Detector and a Accurasil C-18 column (4.6 mm × 250 mm, 5 μm particles, Ameritech, Chicago, IL, USA). Semipreparative HPLC was performed on a system comprising an LC-6AD pump equipped with an SPD-20A UV detector (Shimadzu, Kyoto, Japan) and an Ultimate XB-C18 (10 mm × 250 mm, 5 μm particles) or YMS-Pack-ODS-A (10 mm × 250 mm, 5 μm particles). Silica gel was purchased Qingdao Haiyang Chemical Group Corporation (Qingdao, China).

3.2. Plant Material {#sec3dot2-molecules-21-01175}
-------------------

The roots of *Aconitum szechenyianum* Gay. were collected from the Xi Mountains of Gansu Province of China in July 2014, and identified by senior experimentalist Jitao Wang. A voucher specimen (herbarium No. 20140728) has been deposited in the Medicinal Plants Herbarium (MPH), Shaanxi University of Chinese Medicine, Xianyang, China.

3.3. Extraction and Isolation {#sec3dot3-molecules-21-01175}
-----------------------------

The air-dried and powdered underground parts of *A. szechenyianum* (5.0 kg) were extracted with 80% EtOH at 80 °C for three times (each time 40 L for 1.5 h). After removal of EtOH solvent under reduced pressure, the extract (2 L) was dispersed in water (1.5 L), adjusted with 9% HCl solution to pH 0.8, and extracted with petroleum ether (PE). The acidic water solution was alkalized to pH 10.26 with 25% ammonia solution, extracted with CHCl~3~ three times, and evaporated under pressure to give crude alkaloids (50 g). The crude alkaloids (47 g) were chromatographed on silica gel column, eluting with gradient solvent system (PE/acetone/diethylamine, 50:1:0.1--1:1:0.1) to give 12 fractions (Fr.1--Fr.12). Fr.6 (3.2 g) was purified by HPLC (YMC-Pack-ODS-A, 10 mm × 250 mm, 5 μm particles, flow rate: 1.0 mL·min^−1^) with CH~3~OH/H~2~O (70:30) as mobile phase to obtained Fr.6-1 (30 mg; *t~R~* = 5 min), Fr.6-2 (120 mg; *t~R~* = 30 min), Fr.6-3 (130 mg; *t~R~* = 42 min), Fr.6-4 (120 mg; *t~R~* = 63 min), Fr.6-5 (140 mg; *t~R~* = 77 min), and Fr.6-6 (200 mg; *t~R~* = 63 min). Fr.6-3 (130mg) was purified by HPLC with CH~3~OH/H~2~O (60:40) as mobile phase to afford **1** (13 mg; *t~R~* = 50 min) and **2** (12 mg; *t~R~* = 65 min). Fr.6-4 (120 mg) was purified by HPLC with CH~3~OH/H~2~O (65:35) as mobile phase to afford **3** (10 mg; *t~R~* = 45 min), **4** (20 mg; *t~R~* = 65 min), and **5** (25 mg; *t~R~* = 75 min). See more detailed spectrums in the [supplementary materials](#app1-molecules-21-01175){ref-type="app"}.

*(A-c)-14α-Benzoyloxy-8β-acetoxyl-13β,15α-dihydroxy-1α,6α,16β,18β-tetramethoxy-19-en-aconitane* (*szechenyianine* A): A white amorphous powder, ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{20}$ +60.2 (*c* 0.38, MeOH), IR (KBr) ν~max~: 3508, 2936, 1718, 1637 and 714 cm^−1^; ^1^H-NMR (400 MHz, CDCl~3~) and ^13^C-NMR (100 MHz, CDCl~3~) spectral data, see [Table 1](#molecules-21-01175-t001){ref-type="table"}; *m/z* 600.2842 \[M + H\]^+^ (calcd. for C~32~H~41~NO~10~, 600.2809).

*(A-c)-14α-Benzoyloxy-8β-acetoxyl-13β,15α-dihydroxy-1α,6α,16β,18β-tetramethoxy-19-en-aconitane-N-oxide (szechenyianine B)*: A white amorphous powder, \[α\]${}_{D}^{20}$ +10.5 (*c* 0.44, MeOH), IR (KBr) ν~max~: 3510, 2938, 1719, 1603 and 716 cm^−1^; ^1^H-NMR (400 MHz, CDCl~3~) and ^13^C-NMR (100 MHz, CDCl~3~) spectral data, see [Table 1](#molecules-21-01175-t001){ref-type="table"}; *m/z* 616.2783 \[M + H\]^+^ (calcd. for C~32~ H~41~NO~11~, 616.2758).

*(A-c)-14α-Benzoyloxy-13β,15α-dihydroxy-1α,6α,16β,18β-tetramethoxy-7(8),17-dien-7,17-secoaconitane (szechenyianine C)*: A white amorphous powder, \[α\]${}_{D}^{20}$ +21.6 (*c* 0.64, MeOH), IR (KBr) ν~max~: 3513, 2930, 2824, 1716, 1645, 1453, 1367, 1275, 1102 and 715 cm^−1^; ^1^H-NMR (400 MHz, CDCl~3~) and ^13^C-NMR (100 MHz, CDCl~3~) spectral data, see [Table 1](#molecules-21-01175-t001){ref-type="table"}; *m/z* 542.2783 \[M + H\]^+^ (calcd. for C~30~ H~39~NO~8~, 542.2754).

3.4. Inhibitory Assay of NO Production {#sec3dot4-molecules-21-01175}
--------------------------------------

Assays for NO production were carried out according to the Griess reaction, using dexamethasone as positive control. Briefly, RAW264.7 cells were seeded into 96-well microplates at a density of 2 × 10^5^ mL^−1^ and allowed to adhere for 4 h. RPMI1640 (100 μL) containing test samples (final concentration of 10, 5, 1, 0.5, 0.1, and 0.05 μM) dissolved in DMSO (final concentration less than 0.2%) and LPS (final concentration of 1 μg·mL^−1^) were added. After incubation at 37 °C for 18 h, 50 μL of cell-free supernatant was mixed with 50 μL of Griess Reagent I and 50 μL of Griess Reagent II to determine NO production. Absorbance was measured at 550 nm against a calibration curve with NaNO~2~ standard. The NO productions of the isolated compounds were tested ([Figure 5](#molecules-21-01175-f005){ref-type="fig"}), the inhibitory rate on NO production induced by LPS was calculated by the NO~2~^−^ levels as follows: Inhibitory rate (%) = 100 × (\[NO~2~^−^\]~LPS~ − \[NO~2~^−^\]~LPS+sample~)/(\[NO~2~^−^\]~LPS~ − \[NO~2~^−^\]~untreated~), the IC~50~ values were calculated ([Table 2](#molecules-21-01175-t002){ref-type="table"}). Values are mean ± SD, *n* = 3, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 vs. LPS treated.
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**Sample Availability:** Samples of the compounds **4**--**5** are available from the authors.

###### 

Click here for additional data file.

IR, HR-ESI-MS, ^1^H-NMR, ^13^C-NMR and 2D NMR spectra for compounds **1**--**3** can be found, in the online version, at <http://www.mdpi.com/1420-3049/21/9/1175/s1>.
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![Key ^1^H-^1^H COSY (H![](molecules-21-01175-i002.jpg)H), HMBC (H→C) and ROESY (H↔H) correlations of compound **2**.](molecules-21-01175-g003){#molecules-21-01175-f003}
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![NO inhibitory effects of compounds from *A. szechenyianum* on LPS-activated RAW264.7 cells. Results represent the mean ± SD of three independent experiments; results differ significantly from the LPS-treated, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001; dexamethasone (DEX) was used as a positive control.](molecules-21-01175-g005){#molecules-21-01175-f005}

molecules-21-01175-t001_Table 1

###### 

^1^H-NMR and ^13^C-NMR spectral data of compounds **1**--**5**.

  NO.                    1                      2                      3       4                      5                                      
  ---------------------- ---------------------- ---------------------- ------- ---------------------- ------- ---------------------- ------- -------
  1                      82.3                   3.20 (d, 4.1)          80.5    3.32 (m)               89.6    2.99 (dd, 4.4, 11.3)   81.0    82.3
  2                      22.9                   1.66 (m, H-2a)         22.0    1.45 (m, H-2a)         24.7    1.10 (m)               31.8    23.5
  1.57 (m, H-2b)         1.81 (m, H-2b)         1.86 (m)                                                                                     
  3                      28.2                   1.63 (m, H-3a)         29.5    1.70 (m, H-3a)         37.4    1.55 (m)               72.3    29.0
  1.64 (m, H-3b)         1.79 (m, H-3b)         1.69 (m)                                                                                     
  4                      46.8                                          42.1                           39.7                           43.2    39.0
  5                      45.8                   2.23 (d, 7.1)          44.7    2.35 (d, 7.0)          46.2    2.32 (d, 8.9)          51.2    48.7
  6                      84.1                   3.92 (d, 7.1)          82.7    4.00 (d, 7.0)          80.1    4.45 (m)               83.8    83.2
  7                      49.6                   2.87 (s)               49.7    3.30 (s)               132.1   5.62 (d, 5.5)          45.2    43.6
  8                      90.6                                          89.3                           137.5                          91.7    91.5
  9                      42.6                   2.70 (t, 6.1)          41.9    2.74 (m)               43.0    3.18 (s)               43.9    43.2
  10                     40.6                   2.17 (m)               39.1    2.26 (m)               41.7    2.43 (s)               40.9    40.3
  11                     51.4                                          51.9                           48.5                           49.4    49.7
  12                     36.4                   2.20 (m, H-12a)        36.5    2.27 (m, H-12a)        38.9    2.45 (m)               35.2    35.4
  2.21 (m, H-12b)        1.98 (m, H-12b)                                                                                                     
  13                     74.3                                          74.1                           75.6                           74.4    74.0
  14                     79.3                   4.90 (d, 4.9)          78.8    4.89 (d, 4.8)          79.4    5.08 (d, 4.2)          79.1    78.9
  15                     78.9                   4.48 (dd, 2.9, 5.3)    78.7    4.48 (dd, 3.0, 4.9)    74.1    4.80 (dd, 3.0, 5.8)    79.2    79.0
  16                     89.9                   3.42 (d, 5.3)          89.6    3.45 (d, 5.0)          92.2    3.30 (d, 6.0)          90.0    89.5
  17                     60.6                   3.97 (s)               72.9    4.02 (s)               166.4   7.86 (br s)            55.8    56.7
  18                     78.2                   3.78 (d, 8.5, H-18a)   77.9    3.79 (d, 8.5, H-18a)   80.6    3.16 (d, 8.4)          73.8    79.8
  3.42 (d, 8.5, H-18b)   3.33 (d, 8.5, H-18b)   3.86 (d, 8.4)                                                                                
  19                     165.9                  7.31 (s)               138.9   6.70 (d, 1.2)          58.3    3.53 (m)               41.6    49.0
  3.45 (m)                                                                                                                                   
  8-OAc                  172.6                                         172.1                                                         172.3   172.0
                         21.5                   1.32 (s)               21.4    1.32 (s)                                              21.5    21.3
  1-OCH~3~               56.3                   3.18 (s)               56.6    3.21 (s)               58.2    3.20 (s)               56.0    55.4
  6-OCH~3~               57.4                   3.03 (s)               57.3    3.05 (s)               56.9    3.19 (s)               58.3    57.9
  16-OCH~3~              61.3                   3.75 (s)               61.4    3.77 (s)               61.8    3.75 (s)               61.4    61.1
  18-OCH~3~              59.3                   3.29 (s)               59.3    3.27 (s)               59.1    3.27 (s)               59.1    59.1
  ArC=O                  166.2                                         166.2                          166.4                          166.2   165.9
  ArC-1′                 130.0                                         129.9                          130.0                          130.0   130.7
  3′, 5′                 128.9                  7.43 (t, 7.6)          129.0   7.44 (t, 7.3)          128.7   7.42 (t, 7.5)          128.9   128.6
  2′, 6′                 129.8                  8.02 (d, 7.6)          129.9   8.01 (d, 7.3)          130.1   8.03 (d, 7.5)          129.8   129.6
  4′                     133.6                  7.55 (t, 7.6)          133.8   7.57 (t, 7.3)          133.5   7.53 (t, 7.5)          133.5   133.3

δ in CDCl~3,~ in ppm from TMS; coupling constants (*J*) in Hz; ^1^H-NMR at 400 MHz and ^13^C-NMR at 100 MHz.
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###### 

IC~50~ values of the compounds from *A. szechenyianum* on NO production in LPS-activated RAW264.7 cells.

  Compound      1              2             3             4             5              Dexamethasone
  ------------- -------------- ------------- ------------- ------------- -------------- ---------------
  IC~50~ (μM)   36.62 ± 6.86   3.30 ± 0.11   7.46 ± 0.89   8.09 ± 1.31   11.73 ± 1.94   8.32 ± 1.45

Results are expressed as IC~50~ values in μM and the values are means ± SD; *n* = 3; dexamethasone was used as a positive control.

[^1]: These authors contribute equally to this work.
